BOSTON, December 10, 2015: Morgan Lewis represented specialty vaccines company PaxVax, Inc. in the $105 million investment by an affiliated investment entity of Cerberus Capital Management, one of the world’s leading private investment firms. The transaction was announced on December 8.
The Morgan Lewis team advising PaxVax, Inc. was led by partner Andrew White. Partners Daniel Nelson, Bart Bassett, Jean Cogill and Marion Giliberti Barish provided support. Of counsel Jill Weintraub and associates Kristen Ferris, Jacquelyn Burke, Erin Powers Brennan, Ryan Sykora, Stefan Lefebvre, and Meghan McCarthy contributed to the effort as well.
You can read a press release issued by PaxVax on the investment here.